ClinicalTrials.gov
ClinicalTrials.gov Menu

Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib (GIDEON)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00812175
Recruitment Status : Completed
First Posted : December 22, 2008
Last Update Posted : October 17, 2016
Sponsor:
Information provided by (Responsible Party):
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2012
  Actual Study Completion Date : April 2012
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):